Analytics & PAT
Mass spectrometry in biopharmaceutical characterisation
Why multiple charging brings large proteins within reach of ordinary analysers, what resolving power has to deliver to see a single deamidation, and why ion suppression makes a matrix-matched standard non-negotiable for quantitation.
Mass spectrometry weighs ions, so the first problem with a protein is that it is neither an ion nor in the gas phase. Electrospray solves both. A liquid stream is pushed through a needle held at a few kilovolts; charge accumulates at the meniscus until electrostatic stress overcomes surface tension, drawing out a Taylor cone that emits fine charged droplets. Solvent evaporates, charge density rises, and each droplet reaches the Rayleigh limit and fissions. The protein is released carrying many protons at once.
Multiple charging is what makes the technique possible at all. Analysers separate by mass-to-charge ratio, not mass, so a 150 kDa antibody carrying forty charges appears near m/z 3,750 — well inside an ordinary instrument’s range. A charge-state envelope of many peaks is then deconvoluted into a single mass.
What resolving power has to buy
The modifications that matter in biopharmaceutical characterisation are small. Oxidation of a methionine adds about 15.995 Da. Deamidation of asparagine adds 0.984 Da — a mass difference so slight that on a multiply charged ion it must be resolved against the natural isotope pattern of a molecule containing thousands of carbon atoms. This is the work high-resolution analysers do. An Orbitrap detects the image current induced by ions oscillating in an electrostatic field, where oscillation frequency depends on m/z, and recovers the spectrum by Fourier transform; resolution grows with the length of the transient recorded, which sets a direct trade against how many spectra can be taken across a narrow chromatographic peak. Time-of-flight instruments measure flight time over a fixed path, with a reflectron compensating the spread in initial kinetic energy that would otherwise blur arrival. Triple quadrupoles give up resolution deliberately, isolating one precursor and one fragment, to spend the entire duty cycle on a single transition — which is why trace quantitation of a host cell protein or a leachable is a triple-quadrupole job.
Ion suppression, and why the standard must match the matrix
The measurement’s weakness lives in the ion source. A droplet carries a finite excess charge, and analytes compete for it and for the droplet’s surface. Anything co-eluting with the analyte — salts, residual detergent, polysorbate degradation products, PEG, phospholipids, excipients, abundant peptides from the protein itself — takes a share, alters droplet surface tension and viscosity, or changes the evaporation rate. The analyte’s signal falls, sometimes by an order of magnitude, with no change in its concentration and no indication in the chromatogram.
Suppression is not a fixed instrument property. It varies across the gradient, between sample preparations, between production lots and between batches of a formulated drug product. A calibration curve built in clean solvent therefore measures a different sensitivity from the one the sample experiences, and reports a concentration that is wrong by an unknown factor.
The two defences follow directly from the mechanism. Prepare standards in a matrix that matches the sample, so the competition is the same. Better, add a stable-isotope-labelled version of the analyte: chemically identical, it co-elutes exactly, suffers identical suppression, and is distinguished only by mass — so the ratio of analyte to standard survives a source effect that destroys either signal alone. Without one, an absolute concentration from electrospray should be read as an estimate, because response factors differ per peptide and the method is not intrinsically quantitative.